Search
Showing results for "lung disease preterm"
Research has discovered the first concrete evidence linking Vitamin D deficiency with poorer lung function and changes in lung growth.
Surfactant is a well-established therapy for preterm neonates affected by respiratory distress syndrome (RDS). The goals of different methods of surfactant administration are to reduce the duration of mechanical ventilation and the severity of bronchopulmonary dysplasia (BPD); however, the optimal administration method remains unknown.
While maternal high fat diet compromised litter survival, it also promoted somatic and lung growth (increased lung volume) in the offspring
The key to improving the lung health of Aboriginal children lies in establishing strong community connections.
Researchers from The Kids Research Institute Australia are sharing expertise and knowledge to end rheumatic heart disease in this country.
This chapter deals with asbestos-related non-malignant pleural disease and mesothelioma.
In this translational review, the mechanisms, roles, and impact of epithelial-mesenchymal transition in chronic lung diseases are discussed
This paper is a review of lung function tests best suited to use for early detection of lung disease in Cystic Fibrosis.
Chorioamnionitis is a common antecedent of preterm birth and induces inflammation and oxidative stress in the fetal lungs. Reducing inflammation and oxidative stress in the fetal lungs may improve respiratory outcomes in preterm infants. Creatine is an organic acid with known anti-inflammatory and antioxidant properties.
The extent of lung hypoplasia impacts the survival and severity of morbidities associated with congenital diaphragmatic hernia.